113 results on '"Wen, Patrick Y"'
Search Results
2. Updated Response Assessment in Neuro-Oncology (RANO) for Gliomas
3. Author Correction: Liquid biopsy epigenomic profiling for cancer subtyping
4. Liquid biopsy epigenomic profiling for cancer subtyping
5. Clinical trial links oncolytic immunoactivation to survival in glioblastoma
6. Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma
7. Molecular Profiling and Targeted Therapies in Gliomas
8. Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival
9. Correcting the drug development paradigm for glioblastoma requires serial tissue sampling
10. Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results
11. Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours
12. Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial
13. Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
14. The design and evaluation of hybrid controlled trials that leverage external data and randomization
15. Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma
16. Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma
17. Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours
18. Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients
19. DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis
20. Medical and Neurological Management of Brain Tumor Complications
21. Genomic landscape of gliosarcoma: distinguishing features and targetable alterations
22. Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and 18F-FMISO PET
23. Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastoma
24. Phase 2 trial of hypoxia activated evofosfamide (TH302) for treatment of recurrent bevacizumab-refractory glioblastoma
25. Neurologic Complications of Cranial Radiation Therapy and Strategies to Prevent or Reduce Radiation Toxicity
26. Novel Therapies for Glioblastoma
27. Mechanisms and therapeutic implications of hypermutation in gliomas
28. Fertility preservation outcomes in women with gliomas: a retrospective case–control study
29. A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
30. Glioma progression through synaptic activity
31. Clinical pharmacokinetics and pharmacodynamics of ivosidenib, an oral, targeted inhibitor of mutant IDH1, in patients with advanced solid tumors
32. Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
33. Local control after brain-directed radiation in patients with cystic versus solid brain metastases
34. Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium
35. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
36. Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide
37. Quo Vadis—Do Immunotherapies Have a Role in Glioblastoma?
38. Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate
39. Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone
40. Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival
41. The Viral Connection to Glioblastoma
42. Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas
43. Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials
44. Clinical Relevance of Steroid Use in Neuro-Oncology
45. Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma
46. Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate
47. Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma
48. Assessment of Brain Tumor Response: RANO and Its Offspring
49. Case Report: Next generation sequencing identifies a NAB2-STAT6 fusion in Glioblastoma
50. Progress in glioma diagnosis, classification and treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.